The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.
Linwen ZhuZhe LiXiuchong YuYao RuanYijing ShenYongfu ShaoXinjun ZhangGuoliang YeJunming GuoPublished in: Stem cell research & therapy (2021)
tRF-5026a (tRF-18-79MP9P04) is a promising biomarker for gastric cancer diagnostics and has tumor suppressor effects mediated through the PTEN/PI3K/AKT signaling pathway.